Respiratory Syncytial Virus Immunoprophylaxis: Issues in Short-term and Longer-term Impact

Pediatrics. 2019 Jul;144(1):e20190153. doi: 10.1542/peds.2019-0153.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antiviral Agents*
  • Cystic Fibrosis*
  • Humans
  • Palivizumab
  • Respiratory Syncytial Virus Infections*
  • Respiratory Syncytial Viruses

Substances

  • Antiviral Agents
  • Palivizumab